Rasagiline | List of Frontiers open access articles

Original Research

Published on 02 Nov 2010

The New Inhibitor of Monoamine Oxidase, M30, has a Neuroprotective Effect Against Dexamethasone-Induced Brain Cell Apoptosis

in Neuropharmacology

Shakevia Johnson
Xiao-Ming Ou

Frontiers in Neuroscience

doi 10.3389/fnins.2010.00180

11,495 views
28 citations

Clinical Trial

Published on 03 Dec 2020

Pharmacokinetics and Bioequivalence of Rasagiline Tablets in Chinese Healthy Subjects Under Fasting and Fed Conditions: An Open, Randomized, Single-Dose, Double-Cycle, Two-Sequence, Crossover Trial

in Neuropharmacology

Yinjuan Li
Lu Qi
Haihong Bai
Ying Liu
Rongxia Fan
Yongrui Tu
Yongqiang Sun
Juxiang Wang
Qi Qi
Xiaohui Feng

Frontiers in Pharmacology

doi 10.3389/fphar.2020.571747

9,327 views
9 citations

Original Research

Published on 22 Dec 2021

Engineering of Reductive Aminases for Asymmetric Synthesis of Enantiopure Rasagiline

in Bioprocess Engineering

Kai Zhang
Yuanzhi He
Jiawei Zhu
Qi Zhang
Luyao Tang
Li Cui
Yan Feng

Frontiers in Bioengineering and Biotechnology

doi 10.3389/fbioe.2021.798147

8,336 views
6 citations

Case Report

Published on 25 Feb 2026

Case Report: A possible novel adult-onset, progressive MAO-A hypofunction

in Autonomic Neuroscience

Stefan Berteau
Erik Armitano

Frontiers in Neuroscience

doi 10.3389/fnins.2026.1743519

1,068 views

Systematic Review

Published on 04 Feb 2026

Efficacy of MAO-B and COMT inhibitors on quality of life in patients with Parkinson’s disease: a Bayesian network meta-analysis

in Movement Disorders

Sung Ryul Shim
Yu Jin Jung
Kyum-Yil Kwon
Taeho Greg Rhee
Seon-Min Lee

Frontiers in Neurology

doi 10.3389/fneur.2026.1753555

1,661 views
1 citation

Original Research

Published on 02 Aug 2019

Selegiline Recovers Synaptic Plasticity in the Medial Prefrontal Cortex and Improves Corresponding Depression-Like Behavior in a Mouse Model of Parkinson’s Disease

in Emotion Regulation and Processing

Motoki Okano
Kazue Takahata
Junya Sugimoto
Shizuko Muraoka

Frontiers in Behavioral Neuroscience

doi 10.3389/fnbeh.2019.00176

11,454 views
22 citations

Review

Published on 24 Oct 2025

Fatigue and neuropsychiatric symptoms in Parkinson’s disease: a narrative review

in Dementia and Neurodegenerative Diseases

Lidia Bojtos
Jon Rodríguez-Antigüedad
Javier Pagonabarraga
Saül Martínez-Horta
Jaime Kulisevsky

Frontiers in Neurology

doi 10.3389/fneur.2025.1670644

2,821 views

Original Research

Published on 03 May 2017

Selegiline Ameliorates Depression-Like Behavior in Mice Lacking the CD157/BST1 Gene, a Risk Factor for Parkinson’s Disease

in Emotion Regulation and Processing

Satoka Kasai
Toru Yoshihara
Olga Lopatina
Katsuhiko Ishihara
Haruhiro Higashida

Frontiers in Behavioral Neuroscience

doi 10.3389/fnbeh.2017.00075

14,865 views
51 citations

Articles

The New Inhibitor of Monoamine Oxidase, M30, has a Neuroprotective Effect Against Dexamethasone-Induced Brain Cell Apoptosis

Pharmacokinetics and Bioequivalence of Rasagiline Tablets in Chinese Healthy Subjects Under Fasting and Fed Conditions: An Open, Randomized, Single-Dose, Double-Cycle, Two-Sequence, Crossover Trial

Engineering of Reductive Aminases for Asymmetric Synthesis of Enantiopure Rasagiline

Case Report: A possible novel adult-onset, progressive MAO-A hypofunction

Efficacy of MAO-B and COMT inhibitors on quality of life in patients with Parkinson’s disease: a Bayesian network meta-analysis

Selegiline Recovers Synaptic Plasticity in the Medial Prefrontal Cortex and Improves Corresponding Depression-Like Behavior in a Mouse Model of Parkinson’s Disease

Fatigue and neuropsychiatric symptoms in Parkinson’s disease: a narrative review

Selegiline Ameliorates Depression-Like Behavior in Mice Lacking the CD157/BST1 Gene, a Risk Factor for Parkinson’s Disease